Discovery & Development

How can the NLRP3 inflammasome can be exploited to slow the decline associated with Alzheimer's disease?

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus.

Jan Cools of the VIB Center for Cancer Biology discusses his experience with Mission Bio’s new DNA sequencing platform.

Antibody drug conjugates are starting to transform cancer treatments, so let’s maintain the momentum.

Biotech companies need good patient samples, but hospitals are not always obliging...

Researchers at Trinity College Dublin explain how they are reaching into the natural environment to source new bioactives.

Analytical science has a key role to play in the development of new pharmaceutical products – from discovery, to protein analysis, to quality control.

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.

A wall of data stands between humankind and a revolution in our understanding of the body and its systems. AI can tear it down.

In this video interview, Mike Rea explains why each drug needs its own launch strategy.